XML 43 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Unaudited Quarterly Financial Data
12 Months Ended
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]  
Condensed unaudited quarterly financial data
Condensed unaudited quarterly financial data
 
Three Months Ended
 
 
March 31

 
June 30

 
September 30

 
December 31

(in millions of U.S. dollars, except per share data)
2018

 
2018

 
2018

 
2018

Net premiums earned
$
7,027

 
$
7,664

 
$
7,908

 
$
7,465

Net investment income
806

 
828

 
823

 
848

Net realized gains (losses) including OTTI
(2
)
 
18

 
19

 
(687
)
Total revenues
$
7,831

 
$
8,510

 
$
8,750

 
$
7,626

Losses and loss expenses
$
4,102

 
$
4,487

 
$
4,868

 
$
4,610

Policy benefits
$
151

 
$
150

 
$
127

 
$
162

Net income
$
1,082

 
$
1,294

 
$
1,231

 
$
355

Basic earnings per share
$
2.32

 
$
2.78

 
$
2.66

 
$
0.77

Diluted earnings per share
$
2.30

 
$
2.76

 
$
2.64

 
$
0.76



Net income for the three months ended December 31, 2018 included after-tax catastrophe losses of $506 million.
 
Three Months Ended
 
 
March 31

 
June 30

 
September 30

 
December 31

(in millions of U.S. dollars, except per share data)
2017

 
2017

 
2017

 
2017

Net premiums earned
$
6,772

 
$
7,237

 
$
7,807

 
$
7,218

Net investment income
745

 
770

 
813

 
797

Net realized gains (losses) including OTTI
(7
)
 
101

 
(10
)
 

Total revenues
$
7,510

 
$
8,108

 
$
8,610

 
$
8,015

Losses and loss expenses
$
3,789

 
$
4,146

 
$
6,247

 
$
4,272

Policy benefits
$
168

 
$
163

 
$
169

 
$
176

Net income (loss)
$
1,093

 
$
1,305

 
$
(70
)
 
$
1,533

Basic earnings (loss) per share
$
2.33

 
$
2.79

 
$
(0.15
)
 
$
3.29

Diluted earnings (loss) per share
$
2.31

 
$
2.77

 
$
(0.15
)
 
$
3.27



Net income for the three months ended September 30, 2017 included after-tax catastrophe losses of $1.5 billion. Net income for the three months ended December 31, 2017 included a one-time income tax transition benefit of $450 million related to the 2017 Tax Act. Refer to Note 7 for additional information.